CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women
oleh: Cheryl Baxter, Nonhlanhla Yende Zuma, Natasha Samsunder, Salim Abdool Karim, Catherine Hankins, Quarraisha Abdool Karim, Bruno Pozzetto, Leila Mansoor, Tanuja Narayansamy Gengiah, Ishana Harkoo, Precious Radebe, B Maharaj, Marc M Baum, John A Moss
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2022-01-01 |
Deskripsi
No description available for this item.